Value-at-Risk’s Enduring Legacy and the Future of Market Risk Capital For three decades, Value-at-Risk (VAR) has been a cornerstone of financial regulation, a survivor of crises that have reshaped the global economy. This article delves into VAR’s evolution, its current status, and what the future holds for market risk capital, drawing on recent data and … Read more
Trade Wars and Tech Titans: Navigating the Shifting Sands of Global Commerce The global economic landscape is in constant flux, with trade talks and regulatory battles reshaping the future of international commerce. This article dives into the core issues currently driving these changes, offering insights into the key players and potential outcomes. The Digital Services … Read more
Bank of England’s Credit Risk Overhaul: What’s at Stake? The financial world is watching as the Bank of England (BoE) considers reshaping its approach to credit risk, particularly concerning the Herfindahl-Hirschman Index (HHI). This index, used to measure concentration risk, is under scrutiny, and experts are urging the Prudential Regulation Authority (PRA) to integrate any … Read more
“No Mercy” from European Supervisors: What’s Next for SA-CVA Approvals? The financial world is constantly evolving, and regulatory landscapes are no exception. The recent focus of European supervisors on the Standardised Approach for Counterparty Credit Risk (SA-CVA) approvals highlights a crucial trend: increased scrutiny and a demand for robust compliance. This article dives deep into … Read more
Illinois Interchange Fee Delay: A Glimpse into the Future of Payment Regulations The recent decision by the Government of Illinois to postpone the enforcement of its Interchange Fee Prohibition Act offers a fascinating look into the evolving landscape of payment processing and the ongoing battle between merchants, banks, and regulatory bodies. The delay, pushing the … Read more
Wegovy, Ozempic, and Vision: Navigating the Rare Eye Condition Risk As someone who closely follows advancements in healthcare, particularly in weight management and diabetes treatment, I’ve been tracking developments around the popular drugs Wegovy and Ozempic. Recent news from the European Medicines Agency (EMA) highlights a critical concern: a potential increased risk of a rare … Read more
Decoding the EU’s Regulatory Maze: Future Trends in CSRD and GDPR As a seasoned journalist covering the ever-evolving landscape of European Union regulations, I’ve seen firsthand how new directives can send ripples of both excitement and anxiety through businesses of all sizes. Today, we’re diving deep into two key players: the Corporate Sustainability Reporting Directive … Read more
The Regulatory Pendulum: Navigating the Shifting Sands of Finance As the political landscape shifts, so too does the world of finance. The “regulatory pendulum” is a familiar concept in American financial circles, describing the cyclical shift in priorities and enforcement that occurs after a presidential election. New administrations bring new philosophies, and with them, appointees … Read more
The Tug-of-War in Medical Cannabis Regulation: Insights and Future Trends The medical cannabis landscape continues to evolve, driven by legislative actions and contentious appointments. With lawmakers set to revisit the medical cannabis regulations in Nebraska, the state’s political divide over the issue offers a glimpse into north American trends. Amidst these shifts, key stakeholders dispute … Read more
The Battle of Giants: Understanding Meta’s Legal Maneuvers Meta has recently filed a motion seeking a judgment in an ongoing antitrust case with the Federal Trade Commission (FTC). At the heart of the matter are Meta’s acquisitions of Instagram and WhatsApp, which the FTC claims were moves to unlawfully monopolize the social networking market. Deciphering … Read more